On Monday, Sagimet Biosciences Inc (NASDAQ: SGMT) was 10.77% up from the session before settling in for the closing price of $7.52. A 52-week range for SGMT has been $1.73 – $11.41.
During the last 5-year period, the sales drop of Healthcare Sector giant was -16.85%. When this article was written, the company’s average yearly earnings per share was at -15.38%. With a float of $26.25 million, this company’s outstanding shares have now reached $30.67 million.
Sagimet Biosciences Inc (SGMT) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Sagimet Biosciences Inc stocks. The insider ownership of Sagimet Biosciences Inc is 19.27%, while institutional ownership is 30.53%. The most recent insider transaction that took place on Jul 21 ’25, was worth 598,115. In this transaction President & CEO of this company sold 65,478 shares at a rate of $9.13, taking the stock ownership to the 689,722 shares. Before that another transaction happened on Jul 21 ’25, when Company’s Chief Medical Officer sold 8,277 for $9.13, making the entire transaction worth $75,607. This insider now owns 106,936 shares in total.
Sagimet Biosciences Inc (SGMT) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.45 earnings per share (EPS) during the time that was less than consensus figure (set at -0.4) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -15.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.10% during the next five years compared to -16.85% drop over the previous five years of trading.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
You can see what Sagimet Biosciences Inc (SGMT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 17.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.85, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
Looking closely at Sagimet Biosciences Inc (NASDAQ: SGMT), its last 5-days average volume was 0.48 million, which is a drop from its year-to-date volume of 0.95 million. As of the previous 9 days, the stock’s Stochastic %D was 40.22%.
During the past 100 days, Sagimet Biosciences Inc’s (SGMT) raw stochastic average was set at 42.54%, which indicates a significant decrease from 53.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.67 in the past 14 days, which was higher than the 0.66 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.41, while its 200-day Moving Average is $5.94. However, in the short run, Sagimet Biosciences Inc’s stock first resistance to watch stands at $8.65. Second resistance stands at $8.96. The third major resistance level sits at $9.47. If the price goes on to break the first support level at $7.82, it is likely to go to the next support level at $7.31. Should the price break the second support level, the third support level stands at $7.00.
Sagimet Biosciences Inc (NASDAQ: SGMT) Key Stats
There are 32,522K outstanding shares of the company, which has a market capitalization of 258.24 million. As of now, sales total 0 K while income totals -45,570 K. Its latest quarter income was 0 K while its last quarter net income were -10,390 K.
